Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

The BSAC Guidelines on Endocarditis were last published in 1998. The Guidelines presented here have been updated and extended to reflect changes in both the antibiotic resistance characteristics of causative organisms and the availability of new antibiotics. Randomized, controlled trials suitable for the development of evidenced-based guidelines in this area are still lacking, and therefore a consensus approach has again been adopted. The Guidelines cover diagnosis and laboratory testing, suitable antibiotic regimens and causative organisms. Special emphasis is placed on common causes of endocarditis, such as streptococci and staphylococci, however, other bacterial causes (such as enterococci, HACEK organisms, Coxiella and Bartonella) and fungi are considered. The special circumstances of prosthetic endocarditis are discussed.

[1]  I. Shalit,et al.  Q fever endocarditis in Israel and a worldwide review. , 1997, Scandinavian journal of infectious diseases.

[2]  J. C. West,et al.  Review of pneumococcal endocarditis in adults in the penicillin era. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Vergara,et al.  Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis , 1994, European Journal of Clinical Microbiology and Infectious Diseases.

[4]  D. Raoult,et al.  Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. , 1999, Archives of internal medicine.

[5]  R. Jones,et al.  Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. , 1999, Diagnostic microbiology and infectious disease.

[6]  M. Sande,et al.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. , 1984, Annals of internal medicine.

[7]  C. Poynton,et al.  Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. , 2003, The Journal of infection.

[8]  Claude Carbón,et al.  Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis , 1987, Antimicrobial Agents and Chemotherapy.

[9]  K. Fuursted,et al.  Different Polymerase Chain Reaction-based Analyses for Culture-negative Endocarditis Caused by Streptococcus pneumoniae , 2003, Scandinavian journal of infectious diseases.

[10]  A. Guyot,et al.  Culture-Positive Bartonella quintana Endocarditis , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  A. P. Ball,et al.  Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis , 1998, Heart.

[12]  P. Francioli,et al.  Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. , 1992, JAMA.

[13]  L. Olaison,et al.  Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Finegold,et al.  Endocarditis due to anaerobic gram-negative bacilli. , 1973, The American journal of medicine.

[16]  N. Snyder,et al.  Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. , 1977, Gastroenterology.

[17]  W. Wilson,et al.  Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis , 1990, Antimicrobial Agents and Chemotherapy.

[18]  V. Andriole,et al.  Streptococcal endocarditis (nonenterococcal, non-group A): single vs combination therapy. , 1979, JAMA.

[19]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  R. Macgregor,et al.  Cardiobacterium hominis: an elusive cause of endocarditis. , 1983, The Journal of infection.

[21]  P. Martín-Dávila,et al.  Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Sunil V. Rao,et al.  Mayo Clinic Proceedings , 2000 .

[23]  R. H. Parker,et al.  Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. , 1980, Annals of internal medicine.

[24]  S. Eykyn,et al.  Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  C. Fìlice,et al.  Management of staphylococcal endocarditis in drug addicts. Combined therapy with oral rifampicin and aminoglycosides. , 1984, The Journal of antimicrobial chemotherapy.

[26]  Didier Raoult,et al.  Culture of Bartonella quintana andBartonella henselae from Human Samples: a 5-Year Experience (1993 to 1998) , 1999, Journal of Clinical Microbiology.

[27]  S. Moreno,et al.  Endocarditis due to ampicillin-resistant nontyphoid Salmonella: cure with a third-generation cephalosporin. , 1990, Reviews of infectious diseases.

[28]  N. Frimodt-Møller,et al.  Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. , 2009, Acta medica Scandinavica.

[29]  R. Steelman,et al.  Increased susceptibility to gingival colonization by specific HACEK microbes in children with congenital heart disease. , 2001, The Journal of clinical pediatric dentistry.

[30]  P. Gallagher,et al.  Group B streptococcal endocarditis: report of seven cases and review of the literature, 1962-1985. , 1986, Reviews of infectious diseases.

[31]  R. Auckenthaler,et al.  Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. , 1987, The Journal of infectious diseases.

[32]  R. Zbinden,et al.  Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Raoult,et al.  Diagnosis of 22 New Cases of Bartonella Endocarditis , 1996, Annals of Internal Medicine.

[34]  D. Raoult,et al.  Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. , 2002, Infectious disease clinics of North America.

[35]  P. Serra,et al.  4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin , 1992, Antimicrobial Agents and Chemotherapy.

[36]  A. Karchmer,et al.  Infections of intracardiac devices. , 2002, Infectious disease clinics of North America.

[37]  G. Rolinson,et al.  Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin , 1970, British medical journal.

[38]  C. Watanakunakorn,et al.  Group A streptococcus endocarditis: report of five cases and review of literature. , 1991, The Journal of infection.

[39]  D. Denning,et al.  Practice Guidelines for Diseases Caused by Aspergillus , 2000 .

[40]  Didier Raoult,et al.  Outcome and treatment of Bartonella endocarditis. , 2003, Archives of internal medicine.

[41]  Tamer Ma,et al.  Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis , 1982 .

[42]  C. A. Wood,et al.  Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon , 1991, Antimicrobial Agents and Chemotherapy.

[43]  P. Davey,et al.  Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial. , 1991, Journal of Antimicrobial Chemotherapy.

[44]  R. Haug New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings , 1994 .

[45]  K. Luh,et al.  Actinobacillus actinomycetemcomitans endocarditis: a report of four cases and review of the literature. , 1991, The Quarterly journal of medicine.

[46]  J. Timpone,et al.  Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  H. Lepidi,et al.  Molecular Diagnosis of Infective Endocarditis by PCR Amplification and Direct Sequencing of DNA from Valve Tissue , 2003, Journal of Clinical Microbiology.

[48]  J. Felner,et al.  Anaerobic bacterial endocarditis. , 1970, The New England journal of medicine.

[49]  J. Duval,et al.  Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus , 1993, Antimicrobial Agents and Chemotherapy.

[50]  M. Wallace,et al.  Stenotrophomonas maltophilia Endocarditis , 2002, Scandinavian journal of infectious diseases.

[51]  D Raoult,et al.  Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. , 1996, The American journal of medicine.

[52]  A. Bayer,et al.  Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. , 1985, The Journal of infectious diseases.

[53]  J. Washington,et al.  The microbiological diagnosis of infective endocarditis. , 1987, The Journal of antimicrobial chemotherapy.

[54]  S. Palmer,et al.  Q-FEVER ENDOCARDITIS IN ENGLAND AND WALES, 1975-81 , 1982, The Lancet.

[55]  R. Greenman,et al.  Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. , 1979, Annals of internal medicine.

[56]  D. Raoult,et al.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis , 1991, Antimicrobial Agents and Chemotherapy.

[57]  A. Bolger,et al.  Diagnosis and management of infective endocarditis and its complications. , 1998, Circulation.

[58]  M. González,et al.  Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  S. Eykyn,et al.  Culture-negative endocarditis: contribution of bartonella infections. , 1997, Heart.

[60]  M. Whitby Fusidic acid in septicaemia and endocarditis. , 1999, International journal of antimicrobial agents.

[61]  A. Badley,et al.  Infective endocarditis caused by HACEK microorganisms. , 1997, Annual review of medicine.

[62]  G. Doern Detection of selected fastidious bacteria. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  J. Perfect,et al.  Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin–dalfopristin in patients intolerant of or failing prior therapy , 2000 .

[64]  Jerome J. Schentag,et al.  Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. , 1984, The Journal of antimicrobial chemotherapy.

[65]  R. T. Miller,et al.  Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. , 1988, Annals of internal medicine.

[66]  W. Dismukes,et al.  Citrobacter diversus endocarditis. , 2000, The American journal of the medical sciences.

[67]  D. Levine,et al.  Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. , 1986, Reviews of infectious diseases.

[68]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[69]  D. Raoult,et al.  Bartonella (Rochalimaea) quintana endocarditis in three homeless men. , 1995, The New England journal of medicine.

[70]  Jerome J. Schentag,et al.  Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  C Flexner,et al.  Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. , 1996, The American journal of medicine.

[72]  W. Littler,et al.  The microbial diagnosis of infective endocarditis. , 2003, The Journal of infection.

[73]  E. Mylonakis,et al.  Infective endocarditis in adults. , 2001, The New England journal of medicine.

[74]  A. Osoba,et al.  HACEK group endocarditis at the Riyadh Armed Forces Hospital. , 1997, The Journal of infection.

[75]  D. Raoult,et al.  Current Knowledge of Bartonella Species , 2022 .

[76]  L. Lutwick,et al.  Infective endocarditis of a native valve due to Acinetobacter: case report and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  C. Watanakunakorn,et al.  Antagonism Between Nafcillin or Oxacillin and Rifampin Against Staphylococcus aureus , 1982, Antimicrobial Agents and Chemotherapy.

[78]  M. Sande,et al.  Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. , 1982, Annals of internal medicine.

[79]  G. Jackson,et al.  Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. , 1988, The American journal of medicine.

[80]  L. Fenelon,et al.  Nosocomial infective endocarditis. , 2000, The Journal of hospital infection.

[81]  D. Raoult,et al.  Mycoplasma endocarditis: two case reports and a review. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  R. Bologna,et al.  Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. , 1991, Reviews of infectious diseases.

[83]  P. Berche,et al.  Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis , 1997, Antimicrobial agents and chemotherapy.

[84]  D. Raoult,et al.  Endocarditis Due to Rare and Fastidious Bacteria , 2001, Clinical Microbiology Reviews.

[85]  S. Eykyn,et al.  Campylobacter fetus endocarditis: two case reports and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  D. Raoult,et al.  Chronic Q Fever: Ninety-two Cases From France, Including 27 Cases Without Endocarditis , 1993 .

[87]  R. Hershow,et al.  Retrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis , 1997, Pharmacotherapy.

[88]  Claude Carbón,et al.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis , 1992, Antimicrobial Agents and Chemotherapy.

[89]  B. Fantin,et al.  In vivo antibiotic synergism: contribution of animal models , 1992, Antimicrobial Agents and Chemotherapy.

[90]  Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.

[91]  T. Yipintsoi,et al.  Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[92]  A. Adgey,et al.  Clinical Q fever in Northern Ireland 1962-1989. , 1990, The Ulster medical journal.

[93]  W. Wilson,et al.  Treatment of streptococcal infective endocarditis. , 1985, The American journal of medicine.

[94]  T. Rakowski,et al.  Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  F. Cockerill,et al.  Infective endocarditis due to unusual or fastidious microorganisms. , 1997, Mayo Clinic proceedings.

[96]  B. R. Reddy,et al.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.

[97]  D. Raoult,et al.  Q Fever 1985‐1998: Clinical and Epidemiologic Features of 1,383 Infections , 2000, Medicine.

[98]  H. B. T. Brooks,et al.  Diagnostic Methods , 1916, The Indian Medical Gazette.

[99]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[100]  P S Cohen,et al.  Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. , 1980, Progress in cardiovascular diseases.

[101]  J. Benedik,et al.  Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients , 2003, Heart.

[102]  I. Smith,et al.  Infective endocarditis with negative blood cultures. An analysis of 52 cases. , 1979, The American journal of medicine.

[103]  D. Mesa,et al.  Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study , 2000, Heart.

[104]  H. Gaya,et al.  Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. , 1996, The Journal of antimicrobial chemotherapy.

[105]  D. Levine,et al.  Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. , 1986, Reviews of infectious diseases.